Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as $8.70 and last traded at $8.70, with a volume of 700 shares trading hands. The stock had previously closed at $8.25.
Oxford BioMedica Trading Up 0.6%
The company’s fifty day moving average is $7.95 and its two-hundred day moving average is $5.98. The company has a current ratio of 1.89, a quick ratio of 1.67 and a debt-to-equity ratio of 3.08.
Oxford BioMedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Pros And Cons Of Monthly Dividend Stocks
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- 10 Best Airline Stocks to Buy
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Where Do I Find 52-Week Highs and Lows?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
